DCF — PROVIDENCE ST JOSEPH MEDICAL CTR
Enterprise Value: $-38.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-38.2M
Enterprise Value
$-12.8M
PV of Cash Flows
$-25.4M
PV of Terminal Value
$-40.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $44.5M | $-2.0M | -5.0% | $-3.9M | $-3.5M |
| Year 2 | $45.8M | $-1.6M | -4.0% | $-3.5M | $-2.9M |
| Year 3 | $47.2M | $-1.2M | -3.0% | $-3.2M | $-2.4M |
| Year 4 | $48.6M | $-1.0M | -2.0% | $-3.0M | $-2.1M |
| Year 5 | $50.1M | $-0.9M | -2.0% | $-3.0M | $-1.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-38.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$43.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000347356204
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5